Proxy Votes Now

Home › Funds › Direxion Shares ETF Trust › Direxion Daily Pharmaceutical & Medical Bull 3X ETF

Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) proxy voting record 2025-2026

Fund family: Direxion Shares ETF Trust · Filed by Direxion Shares ETF Trust (CIK 1424958) · SEC series S000050532

Ticker: PILL (C000159441)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 471 with, 12 against, 0 abstentions (not counted as with management). Shareholder proposals: 2 FOR, 7 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Direxion Shares ETF Trust as a whole

The same two figures as Direxion Shares ETF Trust’s manager page (28,641 ballot items across 25 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsDirexion Shares ETF TrustItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)85.3%45694.4%26,237
Backed environmental and social shareholder proposals at US companiesn/a411.0%620

Where this fund voted differently from most Direxion Shares ETF Trust funds

Each ballot item this fund voted is set against the votes of the other Direxion Shares ETF Trust funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted the same way as most Direxion Shares ETF Trust funds on all 119 items where a comparison was possible.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 95.7% of this fund’s 483 such votes could be given a sector; the other 21 (4.3%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care451122.7%
Industrials1100.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections3103
Audit-related600
Say-on-Pay590
Compensation220
Corporate Governance175
Capital Structure120
Extraordinary Transactions40
Shareholder Rights and Defenses30
Environment or Climate22
Other Social Issues22

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Viatris Inc.December 5, 2025$437,987150
Xeris Biopharma Holdings, Inc.June 4, 2026$404,92540
Eli Lilly and CompanyMay 4, 2026$351,220102
Johnson & JohnsonApril 23, 2026$334,883151
Amneal Pharmaceuticals, Inc.May 6, 2026$321,953120
Organon & Co.June 9, 2026$318,859130
Viatris Inc.May 15, 2026$309,876150
Corcept Therapeutics IncorporatedMay 21, 2026$301,038110

Notable votes against management

MeetingCompanyProposalFundMgmt
May 4, 2026Eli Lilly and CompanyShareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposalForAgainst
May 4, 2026Eli Lilly and CompanyShareholder proposal to prepare an annual lobbying report. Shareholder proposalAgainstFor
April 23, 2026Johnson & JohnsonIndependent Board Chair Shareholder proposalAgainstFor
June 9, 2026Pacira Biosciences, Inc.Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Oliver Benton Curtis III Shareholder proposalWithholdFor
June 9, 2026Pacira Biosciences, Inc.Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Eric de Armas Shareholder proposalWithholdFor
April 23, 2026Pfizer Inc.Adopt an Independent Chair Policy Shareholder proposalAgainstFor
May 5, 2026Bristol-Myers Squibb CompanyShareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposalAgainstFor
May 20, 2026Zoetis Inc.Shareholder proposal to permit shareholder action by written consent. Shareholder proposalForAgainst

Contested meetings

Meetings with a proxy contest or competing nominees (1 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

491 ballot items at 62 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) voted at 62 shareholder meetings of 59 companies, on 491 ballot items in all. Where management made a recommendation, the fund followed it on 97.5% of the items and voted against it 12 times. Its most frequent area of disagreement was corporate governance (5 of its votes against management). It voted on 12 shareholder proposals. It voted FOR the board's own proposals less often than Direxion Shares ETF Trust's funds as a whole (85.3% against 94.4%). It voted the same way as most Direxion Shares ETF Trust funds on every item where a comparison was possible. 1 of its meetings was contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Direxion Shares ETF Trust’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.